Genesis Prize Chairman highlights immense role of Jewish scientists and doctors in combatting the pandemic: "A very proud moment for the entire Jewish community"
JERUSALEM, Jan. 19, 2022 /PRNewswire/ -- Today, The Genesis Prize Foundation announced Dr. Albert Bourla, Chairman and CEO of Pfizer, as the 2022 Genesis Prize Laureate. Dr. Bourla received the largest number of votes in a recently concluded global campaign, during which 200,000 people in 71 countries voted online. The choice of the voters was unanimously endorsed by the nine judges on the Genesis Prize Selection Committee.
In announcing the selection of Dr. Bourla, The Genesis Prize Foundation noted the wide-ranging contribution of numerous Jewish scientists, doctors, and healthcare officials in helping to save lives during the COVID-19 pandemic. The Foundation specifically highlighted the contributions of the following individuals:
Dr. Drew Weissman, Professor of Vaccine Research at the University of Pennsylvania, whose discovery of a novel nucleoside-modified mRNA platform enabled the creation of pioneering mRNA vaccines;
Dr. Mikael Dolsten, Chief Scientific Officer, Pfizer, who guided the development of the Pfizer vaccine in record time;
Dr. Tal Zaks, Chief Medical Officer of Moderna during the development of the successful mRNA 1273 vaccine;
Dr. Joanne Waldstreicher, Chief Medical Officer of Johnson & Johnson, which delivered a successful COVID-19 vector vaccine;
Academician Alexander Gintsburg, Director, Gamaleya Institute for Epidemiology and Microbiology, which developed the Sputnik vaccine;
Dr. Anatoly Altstein, Chief Scientist, Gamaleya Institute for Epidemiology and Microbiology, who led the development of the Sputnik vaccine;
Dr. Rochelle Walensky, Director, US Centers for Disease Control and Prevention, which coordinates the US public health response to the pandemic;
Jeffrey Zients, the White House Coronavirus Response Coordinator, who oversees the US federal government response to the pandemic, including vaccine distribution.
Genesis Prize Chairman Stan Polovets said: "This is a very proud moment, not just for Dr. Bourla, but for the entire Jewish community. A people so small in number are having such an outsized impact on this global effort to save lives."
Meet Mikael Dolsten, the Jewish immigrant leading Pfizer’s vaccine charge
By Gabe Friedman
(JTA) – When Mikael Dolsten, the head scientist at Pfizer, heard the news two weeks ago that the COVID-19 vaccine that he has been helping to develop for the better part of a year was over 90% effective, he and his colleagues literally leapt with joy at a corporate office in Connecticut.
I agree that the graphic is in poor taste.
However, here are some quotes from the Jewish community in the pride it takes in its scientists and their historic achievements in the pandemic:
https://www.prnewswire.com/news-releases/jewish-nobel-awarded-to-pfizer-ceo-albert-bourla-301464272.html
Genesis Prize Chairman highlights immense role of Jewish scientists and doctors in combatting the pandemic: "A very proud moment for the entire Jewish community"
JERUSALEM, Jan. 19, 2022 /PRNewswire/ -- Today, The Genesis Prize Foundation announced Dr. Albert Bourla, Chairman and CEO of Pfizer, as the 2022 Genesis Prize Laureate. Dr. Bourla received the largest number of votes in a recently concluded global campaign, during which 200,000 people in 71 countries voted online. The choice of the voters was unanimously endorsed by the nine judges on the Genesis Prize Selection Committee.
Dr. Drew Weissman, Professor of Vaccine Research at the University of Pennsylvania, whose discovery of a novel nucleoside-modified mRNA platform enabled the creation of pioneering mRNA vaccines;
Dr. Mikael Dolsten, Chief Scientific Officer, Pfizer, who guided the development of the Pfizer vaccine in record time;
Dr. Tal Zaks, Chief Medical Officer of Moderna during the development of the successful mRNA 1273 vaccine;
Dr. Joanne Waldstreicher, Chief Medical Officer of Johnson & Johnson, which delivered a successful COVID-19 vector vaccine;
Academician Alexander Gintsburg, Director, Gamaleya Institute for Epidemiology and Microbiology, which developed the Sputnik vaccine;
Dr. Anatoly Altstein, Chief Scientist, Gamaleya Institute for Epidemiology and Microbiology, who led the development of the Sputnik vaccine;
Dr. Rochelle Walensky, Director, US Centers for Disease Control and Prevention, which coordinates the US public health response to the pandemic;
Jeffrey Zients, the White House Coronavirus Response Coordinator, who oversees the US federal government response to the pandemic, including vaccine distribution.
http://www.jewishledger.com/2020/11/the-jewish-connection-to-the-covid-vaccines/
Meet Mikael Dolsten, the Jewish immigrant leading Pfizer’s vaccine charge
By Gabe Friedman
(JTA) – When Mikael Dolsten, the head scientist at Pfizer, heard the news two weeks ago that the COVID-19 vaccine that he has been helping to develop for the better part of a year was over 90% effective, he and his colleagues literally leapt with joy at a corporate office in Connecticut.